Nov 10, 09
|
| NEW STORY |
| 01:30 ET |
Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide
|
 |
Oct 27, 09
|
| 08:00 ET |
Marsha Fanucci Joins Ironwood Board of Directors
|
|
Sep 14, 09
|
| 12:01 ET |
David Ebersman Joins Ironwood Board of Directors
|
|
| 12:01 ET |
Ironwood Appoints Thomas McCourt As Chief Commercial Officer and Senior Vice President of Marketing and Sales
|
|
May 04, 09
|
| 08:00 ET |
Ironwood Announces Linaclotide European Licensing Agreement with Almirall
|
|
Oct 06, 08
|
| 12:02 ET |
Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
|
|
Oct 01, 08
|
| 11:08 ET |
Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
|
|
Apr 07, 08
|
| 14:00 ET |
Microbia Announces Name Change to Ironwood Pharmaceuticals
|
|
Mar 31, 08
|
| 08:00 ET |
Microbia Appoints Halley Gilbert as Vice President, General Counsel
|
|
May 21, 07
|
| 08:00 ET |
Microbia Announces Positive Phase 2 Results for Its Investigational Compound Linaclotide
|
|
Mar 01, 07
|
| 08:00 ET |
Microbia Raises $50 Million to Advance Clinical Development of Therapeutic Candidates Through Phase 2
|
|
Oct 24, 06
|
| 08:30 ET |
Linaclotide Shown to Improve Symptoms of Chronic Constipation in Phase 2a Study
|
|
May 23, 06
|
| 11:30 ET |
Microbia Presents MD-1100 (Linaclotide Acetate) Phase 1 Results
|
|
Apr 06, 06
|
| 08:32 ET |
George Conrades Joins Microbia Board of Directors
|
|
Feb 27, 06
|
| 08:45 ET |
Microbia Raises $75 Million in Private Equity Financing to Advance Therapeutic Candidates Through Clinical Trials
|
|
Feb 07, 06
|
| 08:33 ET |
Microbia and DuPont Central Research & Development Collaborate to Develop a Novel Biomanufacturing Process
|
|
Nov 01, 05
|
| 08:12 ET |
Microbia Announces Second Collaboration Agreement Between Its Precision Engineering(TM) Unit and Ranbaxy Laboratories
|
|
Oct 31, 05
|
| 08:04 ET |
Microbia Presents Results From Phase 1 Trial Demonstrating Md-1100 is Active and Well-Tolerated in Healthy Volunteers
|
|
Oct 20, 05
|
| 08:34 ET |
Microbia Appoints Dr. Jeffrey M. Johnston as Vice President, Clinical Development and Chief Medical Officer
|
|
Sep 15, 05
|
| 08:31 ET |
Microbia Initiates Phase I Clinical Testing for Next-Generation Compound for the Treatment of High Cholesterol
|
|
Jul 25, 05
|
| 08:32 ET |
Microbia and Bioprocessing Technology Institute Announce Metabolic Engineering Collaboration
|
|
May 17, 05
|
| 14:37 ET |
Microbia Successfully Completes Phase IA Trial of MD-1100 for IBS-C and Other GI Disorders
|
|